CNR Institutional Research Information System

CATALUCCI, DANIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.608
NA - Nord America 829
EU - Europa 415
SA - Sud America 267
AF - Africa 34
Totale 3.153
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 792
SG - Singapore 659
CN - Cina 435
BR - Brasile 212
VN - Vietnam 161
HK - Hong Kong 130
IT - Italia 123
FR - Francia 85
KR - Corea 77
NL - Olanda 73
JP - Giappone 36
FI - Finlandia 28
IN - India 27
GB - Regno Unito 26
AR - Argentina 23
DE - Germania 20
BD - Bangladesh 18
MX - Messico 13
ID - Indonesia 12
ZA - Sudafrica 11
EC - Ecuador 10
CA - Canada 9
IL - Israele 8
MA - Marocco 8
PL - Polonia 8
AT - Austria 7
TR - Turchia 7
PK - Pakistan 6
UA - Ucraina 6
CL - Cile 5
IE - Irlanda 5
PE - Perù 5
CR - Costa Rica 4
SE - Svezia 4
UZ - Uzbekistan 4
VE - Venezuela 4
BE - Belgio 3
CH - Svizzera 3
EG - Egitto 3
ES - Italia 3
GR - Grecia 3
HU - Ungheria 3
IQ - Iraq 3
JO - Giordania 3
PH - Filippine 3
RU - Federazione Russa 3
AL - Albania 2
AO - Angola 2
AZ - Azerbaigian 2
BO - Bolivia 2
BY - Bielorussia 2
CO - Colombia 2
ET - Etiopia 2
HR - Croazia 2
KE - Kenya 2
LV - Lettonia 2
NP - Nepal 2
PA - Panama 2
PY - Paraguay 2
SA - Arabia Saudita 2
TH - Thailandia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
CG - Congo 1
CM - Camerun 1
CU - Cuba 1
CY - Cipro 1
DK - Danimarca 1
GE - Georgia 1
GF - Guiana Francese 1
GP - Guadalupe 1
HN - Honduras 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LT - Lituania 1
OM - Oman 1
PT - Portogallo 1
QA - Qatar 1
SN - Senegal 1
SV - El Salvador 1
UY - Uruguay 1
Totale 3.153
Salva come PNG Salva come JPEG
Città #
Singapore 392
Santa Clara 275
Hefei 185
Hong Kong 128
Beijing 84
San Jose 83
Ashburn 77
Seoul 77
Lauterbourg 67
Ho Chi Minh City 60
Los Angeles 41
Hanoi 34
Tokyo 24
Dallas 23
Milan 22
New York 21
Lappeenranta 19
Orem 15
Pisa 14
Buffalo 13
São Paulo 13
Council Bluffs 12
Bologna 11
Frankfurt am Main 10
Minamishinagawa 10
Cagliari 9
Da Nang 9
Helsinki 8
Rio de Janeiro 8
Warsaw 8
Denver 7
Querétaro 7
Atlanta 6
Brescia 6
Chennai 6
Johannesburg 6
Vienna 6
Amsterdam 5
Bengaluru 5
Chicago 5
Curitiba 5
Guayaquil 5
Phoenix 5
Poplar 5
Porto Alegre 5
Belo Horizonte 4
Brasília 4
Dublin 4
Düsseldorf 4
Hyderabad 4
Jakarta 4
Marseille 4
Montreal 4
Quito 4
Rome 4
Salvador 4
San Francisco 4
Stockholm 4
Amman 3
Assemini 3
Brooklyn 3
Brussels 3
Budapest 3
Bắc Ninh 3
Campinas 3
Cape Town 3
Casablanca 3
Charlotte 3
City of London 3
Faenza 3
Guangzhou 3
Haiphong 3
Kyiv 3
London 3
Mumbai 3
Naples 3
Quảng Ngãi 3
Quận Một 3
Tashkent 3
Thái Nguyên 3
Wuppertal 3
Ankara 2
Annapolis 2
Ascoli Piceno 2
Athens 2
Baku 2
Banda Aceh 2
Bari 2
Benevento 2
Cachoeiro de Itapemirim 2
Cairo 2
Campo Grande 2
Can Tho 2
Caserta 2
Caxias do Sul 2
Córdoba 2
Dalian 2
Florence 2
Fortaleza 2
Go Vap 2
Totale 1.995
Salva come PNG Salva come JPEG
Nome #
Lung-to-Heart Nano-in-Micro Peptide Promotes Cardiac Recovery in a Pig Model of Chronic Heart Failure 109
Calcium Phosphate Nanoparticles as Carriers of Therapeutic Peptides 94
Calcium Phosphate Nanoparticle Precipitation by a Continuous Flow Process: A Design of an Experiment Approach 92
T cell costimulation blockade blunts pressure overload-induced heart failure 90
Bio-Inspired Negatively-Charged Calcium Phosphate Nanocarriers for Cardiac Delivery of MicroRNAs 82
Immersion before dry simulated dive reduces cardiomyocyte function and increases mortality after decompression 79
MicroRNA-1 downregulation increases connexin 43 displacement and induces ventricular tachyarrhythmias in rodent hypertrophic hearts. 79
Synthetic recovery of impulse propagation in myocardial infarction via silicon carbide semiconductive nanowires 79
Dry powder inhalation technology for heart targeting applied to calcium phosphate nanoparticles loaded with active substances 78
Peptide-Based Targeting of the L-Type Calcium Channel Corrects the Loss-of-Function Phenotype of Two Novel Mutations of the CACNA1 Gene Associated With Brugada Syndrome 71
Biocompatible antimicrobial colistin loaded calcium phosphate nanoparticles for the counteraction of biofilm formation in cystic fibrosis related infections 70
Inhalable Microparticles Embedding Biocompatible Magnetic Iron-Doped Hydroxyapatite Nanoparticles 66
Nano-miR-133a Replacement Therapy Blunts Pressure Overload-Induced Heart Failure 66
MicroRNA-133 Controls Vascular Smooth Muscle Cell Phenotypic Switch In Vitro and Vascular Remodeling In Vivo 63
Inhalation of peptide-loaded nanoparticles improves heart failure 63
The noncoding-RNA landscape in cardiovascular health and disease 60
Diagnostic and Therapeutic Aptamers A Promising Pathway to Improved Cardiovascular Disease Management 60
Antimicrobial peptides for tackling cystic fibrosis related bacterial infections: A review 59
Wnt signalling mediates miR-133a nuclear re-localization for the transcriptional control of Dnmt3b in cardiac cells 58
Peptide-Based Targeting of the L-Type Calcium Channel Corrects the Loss-of-Function Phenotype of Two Novel Mutations of the CACNA1 Gene Associated With Brugada Syndrome 58
Myopalladin knockout mice develop cardiac dilation and show a maladaptive response to mechanical pressure overload 58
MODULATION OF LTCC PATHWAYS BY A MELUSIN MIMETIC INCREASES VENTRICULAR CONTRACTILITY DURING LPS-INDUCED CARDIOMYOPATHY 56
Inhalable microparticles embedding calcium phosphate nanoparticles for heart targeting: The formulation experimental design 55
A combined low-frequency electromagnetic and fluidic stimulation for a controlled drug ... 54
MicroRNA-199a-3p and MicroRNA-199a-5p Take Part to a Redundant Network of Regulation of the NOS (NO Synthase)/NO Pathway in the Endothelium. 54
Molecular mechanisms underlying the beneficial effects of exercise and dietary interventions in the prevention of cardiometabolic diseases 53
Content of mitochondrial calcium uniporter (MCU) in cardiomyocytes is regulated by microRNA-1 in physiologic and pathologic hypertrophy 52
Nanomedicine Approaches for the Pulmonary Treatment of Cystic Fibrosis 51
Peptidomimetic Targeting of Cav?2 Overcomes Dysregulation of the L-Type Calcium Channel Density and Recovers Cardiac Function 50
Optimization of In Vivo Studies by Combining Planar Dynamic and Tomographic Imaging: Workflow Evaluation on a Superparamagnetic Nanoparticles System 48
Disease modeling of a mutation in a-actinin 2 guides clinical therapy in hypertrophic cardiomyopathy 48
MicroRNA-133 modulates the b1-adrenergic receptor transduction cascade 45
A combined low-frequency electromagnetic and fluidic stimulation for a controlled drug release from superparamagnetic calcium phosphate nanoparticles: potential application for cardiovascular diseases 45
Mitochondrial a Kinase Anchor Proteins in Cardiovascular Health and Disease: A Review Article on Behalf of the Working Group on Cellular and Molecular Biology of the Heart of the Italian Society of Cardiology 45
MicroRNA-133 controls cardiac myocyte hypertrophy 40
An anti-PDGFR aptamer for selective delivery of small therapeutic peptide to cardiac cells 40
MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice (vol 120, pg 2805, 2010) 39
The Circulating Level of FABP3 Is an Indirect Biomarker of MicroRNA-1 39
Dnmt3a-mediated inhibition of Wnt in cardiac progenitor cells improves differentiation and remote remodeling after infarction 39
Cardiovascular nanomedicine: The route ahead 38
Novel Basic Science Insights to Improve the Management of Heart Failure: Review of the Working Group on Cellular and Molecular Biology of the Heart of the Italian Society of Cardiology 36
Physiological myocardial hypertrophy: how and why? 35
A comparative MudPIT analysis identifies different expression profiles in heart compartments. 35
Biocompatible and inhalable antimicrobial-loaded nanoparticles for the counteraction of biofilm formation and antibiotic resistance: towards a potential new therapy for CF related infections 35
The role of mitochondrial dynamics in cardiovascular diseases 34
Computational simulation of electromagnetic fields on human targets for magnetic targeting applications 34
MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice. 33
Deciphering the beta-adrenergic response in human embryonic stem cell-derived-cardiac myocytes: closer to clinical use? 33
Relationship between downregulation of miRNAs and increase of oxidative stress in the development of diabetic cardiac dysfunction: junctin as a target protein of miR-1. 31
FABP3 as a Biomarker of Heart Pathology 31
An SRF/miR-1 axis regulates NCX1 and annexin A5 protein levels in the normal and failing heart. 31
Role of electromagnetic stimulation on cardiac cells activity and on magnetic nanoparticles for drug delivery to the heart 30
Genome-wide microRNA target gene identification and annotation using multiple prediction algorithms 30
The recent blooming of therapeutic aptamers 30
NF-kB mediated miR-26a regulation in cardiac fibrosis. 29
Neutrophils promote Alzheimer's disease-like pathology and cognitive decline via LFA-1 integrin. 26
Nano-Apatites with Designed Chemistry and Crystallinity for Bone Regeneration and Nanomedical Applications 26
Atrogin-1 deficiency promotes cardiomyopathy and premature death via impaired autophagy 26
High Intensity Interval Training Ameliorates Mitochondrial Dysfunction in the Left Ventricle of Mice with Type 2 Diabetes 25
Enhancement of mitochondrial calcium uptake is cardioprotective against maladaptive hypertrophy by retrograde signaling uptuning Akt 25
Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions. 24
Akt regulates L-type Ca2+ channel activity by modulating Cava1 protein stability 24
The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. 24
MicroRNAs: novel regulators in cardiac development and disease. 23
MicroRNAs and the control of heart pathophysiology 22
Exercise training reverses myocardial dysfunction induced by CaMKII?C overexpression by restoring Ca2+ homeostasis. 22
HEXIM1: a new player in myocardial hypertrophy? 20
MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice 20
Mutual antagonism between IP3RII and miRNA-133a regulates calcium signals and cardiac hypertrophy 20
MiR-153/Kv7.4: a novel molecular axis in the regulation of hypertension 19
AKT INCREASES SARCOPLASMIC RETICULUM CA2+ CYCLING BY DIRECT PHOSPHORYLATION OF PHOSPHOLAMBAN (PLN) AT THR17 18
MiR-133a Regulates Collagen 1A1: Potential Role of miR-133a in Myocardial Fibrosis in Angiotensin II-Dependent Hypertension 17
APJ acts as a dual receptor in cardiac hypertrophy. 17
A Novel Approach for In Vitro Testing and Hazard Evaluation of Nanoformulated RyR2-Targeting siRNA Drugs Using Human PBMCs 16
Reduced aerobic capacity causes leaky ryanodine receptors that trigger arrhythmia in a rat strain artificially selected and bred for low aerobic running capacity 16
Cardiovascular inhalation for targeted drug delivery in cardiac disease 14
Totale 3.356
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.302
article - articoli 9.540
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 297
Totale 20.139
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202412 0 0 0 0 0 0 0 0 0 0 10 2
2024/20251.296 8 6 96 36 332 81 89 62 46 97 246 197
2025/20262.048 131 219 196 336 343 113 325 104 117 109 55 0
Totale 3.356